-
Boston Scientific (Natick, Massachusetts) reported that it has signed an agreement to sell its fluid management and venous access businesses for $425 million in cash to private equity firm Avista Capital Partners, thereby, it said last month, completing its program for spinning off what it termed "non-stategic" assets.
-
Bristol-Myers Squibb (BMS; New York) reported in mid-December that it would sell its Medical Imaging (BMS-MI) unit in Billerica, Massachusetts, to private equity firm Avista Partners (New York) for $525 million in cash.
-
Robert Jarvik, MD, is a name known to many, for his development of the Jarvik 7 and the drama that was the life and death of retired dentist Barney Clark, the person first implanted with that first artificial heart in 1982.
-
A U.S. physician insists that current regulatory policies should be strengthened to ensure acceptable cardiovascular safety of medicines primarily developed for non-cardiovascular applications.
-
It has been fairly common to say that a shock with an automated external cardioverter (AED) must be given to someone experience cardiac arrest within a 10-minute window following initial attack.
-
Edwards Lifesciences; CardioVations Division of Ethicon; C.R. Bard; LeMaitre Vascular; Biomateriali; Sorin Group; MedCath; Heart Hospital of Lafayette; Heart Hospital of Acadiana; Volcano; CardioSpectra
-
Beckman Coulter; Thomas Jefferson University; Laboraf Diagnostica e Ricerca San Raffaele SpA; BioSphere Medical; DuPont Applied BioSciences; GE Healthcare; Draximage; Draxis Health; HemCon Medical Technologies; AutoMedx; Toshiba Medical Systems; TomTec Imaging Systems
-
Catheter ablation reduced the number of shocks delivered to patients who have defibrillators implanted after heart attacks, concluded a study published in late last month in the "New England Journal of Medicine".
-
ATS Medical; Cambridge Heart; Coherex Medical; Escalon Medical; FlowCardia; Heartscape Technologies; InterCure; TherOx
-
St. Jude Medical (St. Paul, Minnesota) reported FDA clearance of its EnSite Fusion Registration Module, new software designed to aid in creating detailed heart models to facilitate the diagnosis and delivery of therapy for complex abnormal atrial heart rhythms, including atrial fibrillation (AF).
